Targeting this signalling pathway with pharmacological inhibitors such as CCR5 blocker Maraviroc, PI3K/AKT inhibitor LY294002 and PI3K inhibitor NVP-BKM120 can suppress tumour cell proliferation [87,90,92,93]. This evidence concerns the gene CCR5 and neoplasm.